dyphylline has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 3 studies
Dyphylline: A THEOPHYLLINE derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis.
dyphylline : An oxopurine that is theophylline bearing a 2,3-dihydroxypropyl group at the 7 position. It has broncho- and vasodilator properties, and is used in the treatment of asthma, cardiac dyspnea, and bronchitis. It is also an ingredient in preparations that have been promoted for coughs.
Chemical and Drug Induced Liver Injury, Chronic: Liver disease lasting six months or more, caused by an adverse effect of a drug or chemical. The adverse effect may be caused by drugs, drug metabolites, chemicals from the environment, or an idiosyncratic response.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chalasani, N | 3 |
Bonkovsky, HL | 2 |
Stine, JG | 1 |
Gu, J | 3 |
Barnhart, H | 3 |
Jacobsen, E | 1 |
Björnsson, E | 1 |
Fontana, RJ | 2 |
Kleiner, DE | 2 |
Hoofnagle, JH | 2 |
Devarbhavi, H | 1 |
Ghabril, M | 1 |
Patil, M | 1 |
Raj, S | 1 |
Li, YJ | 1 |
Dellinger, A | 1 |
Navarro, V | 1 |
Bonkovsky, H | 1 |
Phillips, E | 1 |
Lammert, C | 1 |
Schwantes-An, TH | 1 |
Nicoletti, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Multi-Center, Longitudinal Study of Drug-and CAM-Induced Liver Injury[NCT00345930] | 4,000 participants (Anticipated) | Observational | 2004-09-30 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 other studies available for dyphylline and Chemical and Drug Induced Liver Injury, Chronic
Article | Year |
---|---|
Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study.
Topics: Adult; Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Chemical and Drug Ind | 2022 |
Leflunomide-induced liver injury: Differences in characteristics and outcomes in Indian and US registries.
Topics: Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Drug-Relate | 2022 |
Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.
Topics: Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Dyphylline; | 2023 |